Skip to main content
. 2021 Dec 16;11(12):e053854. doi: 10.1136/bmjopen-2021-053854

Table 4.

Reported asthma-related or bronchial thermoplasty-related adverse events in BTGR subjects

Event All (N) Treatment period (N) 1 year (N) 2 years (N)
Asthma (wheezing/bronchospasm) 293 100 115 71
Lower respiratory infection (bronchitis, pneumonia) 82 28 35 17
Upper respiratory tract infection (influenza, viral, sinusitis) 53 16 26 7
Dyspnoea/breathlessness 21 13 2 3
Haemoptysis 13 12 1 0
Cough 13 5 6 1
Mucous production/plugging 13 10 3 0
Atelectasis 11 11 0 0
Laryngitis, laryngospasm, candidiasis 11 7 1 3
Chest pain/discomfort 8 6 0 2
Respiratory distress/respiratory failure 5 2 3 0
Pneumothorax 2 2 0 0

*In addition, one patient was reported as having bronchomalacia in the treatment period. This was presumed to be a new bronchoscopic finding rather than a sequela of treatment.

BTGR, Bronchial Thermoplasty Global Registry.